Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBio-Sustainable Future Enterprises Regulatory News (BSFA)

Share Price Information for Bio-Sustainable Future Enterprises (BSFA)

Share Price is delayed by 15 minutes
Get Live Data
1.00    -0.01 (-1.00%)
Bid:
0.75
Ask:
1.25
Spread: 0.50 (66.667%)
Market Cap: £1.92m
BSFA Live PriceLast checked at - London Stock Exchange

Intraday Bio-Sustainable Future Enterprises Share Chart

Strategic Shareholding Update

13 Apr 2026 07:00

RNS Number : 0694A
BSF Enterprise PLC
13 April 2026
Β 

13 April 2026

Β 

BSF Enterprise PLC

Β 

Strategic Shareholding Update

Β 

Β 

BSF Enterprise PLC (LSE: BSFA) ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce, further to the Company's announcement of 2 April 2026 regarding the placing of new ordinary shares (the "Placing"), that Mr John Story has acquired a significant beneficial interest in the Company pursuant to the Placing.

Β 

The Company understands that, following settlement, Mr Story is expected to be the largest individual shareholder. A TR-1 notification in respect of this holding is expected to be made in due course following settlement.

Β 

Mr Story is Chairman and a principal shareholder of Peers Hardy (UK) Limited, a well-established watch, jewellery and accessories group supplying major high street retailers and operating a portfolio of consumer brands.

Β 

Peers Hardy has a long track record in the design, sourcing and distribution of fashion and premium watches and accessories, including licensed and owned brands, and has demonstrated an ability to adapt to changing consumer trends within the retail and wearable technology markets.

Β 

The Board believes that Mr Story's experience across retail, branded consumer products and premium accessories is highly relevant to the Company's strategy as it develops its position in high-value, next-generation materials, including its recently unveiled T-Rex Leatherβ„’ product.

Β 

The Company looks forward to engaging with Mr Story as a supportive and strategic shareholder.

Β 

This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

Β 

END

Β 

Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here:

Β 

https://bsfenterprise.com/link/P3DZby

Β 

For further enquiries, please visit www.bsfenterprise.com or contact:

Β 

BSF Enterprise PLC

Geoff Baker - Chairman

Che Connon - CEO & Director

Β 

We encourage all investors to share questions on this announcement via our investor website.

https://bsfenterprise.com/s/a1f22b

Bowsprit Partners

John Treacy

James Sheehan

Β 

Β +44 (0)203 883 4430

Shard Capital (Broker)

Damon Heath

Isabella Pierre

Β 

(0)20 4530 6926

(0)20 4530 6928

ISIN of the Ordinary Shares

is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

Β 

Β 

Β 

Β 

Subscribe to our news alert service: https://bsfenterprise.com/s/bb9f43

Β 

About BSF Enterprise PLC

BSF Enterprise PLC (LSE:BSFA) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather (via LGL), cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free ATEPβ„’ platform, BSF delivers sustainable, high-performance alternatives to conventional materials, targeting global markets where provenance, ethics, and performance are increasingly prized by consumers and brands alike.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDZZGMDVGLGVZM
Date   Source Headline
20th Feb 20233:00 pmRNSNotice of AGM
10th Feb 20237:00 amRNSAllotment of shares
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSUK’s First Fillet of Cultivated Meat Produced
31st Jan 20234:36 pmRNSAnnual Report and Financial Statements
19th Dec 20227:00 amRNS3D Bio-Tissues enters partnership with New Harvest
23rd Nov 20224:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNS3D Bio-Tissues partners with cell growth company
15th Nov 20227:00 amRNSSuccessful Prototypes of Lab-Grown Fillets of Meat
27th Oct 20227:00 amRNS3D Bio-Tissues receives €100,000 grant
21st Sep 20227:00 amRNS3D Bio-Tissues Appoints Business Director
18th Jul 20227:00 amRNSOperational Update
12th Jul 202212:08 pmRNSResults of Annual General Meeting
29th Jun 20227:00 amRNSInterim Financial Statements
17th Jun 20221:43 pmRNSNotice of Annual General Meeting
6th Jun 202210:42 amRNSAppointment of new CFO and opening London Office
17th May 20228:00 amRNSAdmission to Trading and First Day of Dealings
16th May 202210:46 amRNSResults of General Meeting
27th Apr 202212:07 pmRNSConditional Placing to raise £1.75 million
14th Feb 20224:52 pmRNSAnnual Financial Report
24th Dec 202110:58 amRNSAcquisition
16th Aug 20218:13 amRNSProposed Transaction and Suspension of Listing
16th Aug 20217:30 amRNSSuspension - BSF Enterprise Plc
9th Aug 20217:00 amRNSAppointment of Director
4th May 20212:44 pmRNSHalf-year Report
23rd Apr 202112:13 pmRNSHalf-year Report
6th Apr 20218:37 amRNSCorrection Statement
1st Apr 20214:56 pmRNSAGM Statement
1st Apr 20214:54 pmRNSResult of AGM
1st Apr 20217:00 amRNSAnnual Financial Report
1st Apr 20217:00 amRNSNotice of AGM
4th Mar 20213:19 pmRNSAGM Statement
4th Aug 20207:00 amRNSResult of General Meeting 
16th Jul 20207:48 amRNSAcquisition
31st Mar 20207:00 amRNSResult of AGM
26th Mar 202010:49 amRNSNotice Of AGM
3rd Mar 20204:10 pmRNSNotice of Annual General Meeting 2020
3rd Feb 20207:00 amRNSAnnual Financial Report
26th Jul 20198:31 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.